Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Controlled Trial of Combination Antiemetic Therapy With Aprepitant / Fosaprepitant in Patients With Colorectal Cancer Receiving Oxaliplatin-based Chemotherapy

NCT01344304 is registered in ClinicalTrials.gov with Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group as lead sponsor.

NCT NCT01344304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01344304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Controlled Trial of Combination Antiemetic Therapy With Aprepitant / Fosaprepitant in Patients With Colorectal Cancer Receiving Oxaliplatin-based Chemotherapy
Lead sponsor
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2011
Completion date
April 30, 2015
Enrollment
413 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer